BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 14639745)

  • 21. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
    Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
    ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.
    He XC; Feng S; Wang ZF; Shi Y; Zheng S; Xia Y; Jiang H; Tang XC; Bai D
    Bioorg Med Chem; 2007 Feb; 15(3):1394-408. PubMed ID: 17126020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.
    Musilek K; Roder J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Opletalova V; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2011 Jan; 21(1):150-4. PubMed ID: 21144749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
    Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
    Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
    Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
    J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J; Iorga BI; Guillou C
    Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
    Correa-Basurto J; Flores-Sandoval C; Marín-Cruz J; Rojo-Domínguez A; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2007 Jan; 42(1):10-9. PubMed ID: 17055616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.
    Odzak R; Calić M; Hrenar T; Primozic I; Kovarik Z
    Toxicology; 2007 Apr; 233(1-3):85-96. PubMed ID: 16962227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Zhu J; Wu CF; Li X; Wu GS; Xie S; Hu QN; Deng Z; Zhu MX; Luo HR; Hong X
    Bioorg Med Chem; 2013 Jul; 21(14):4218-24. PubMed ID: 23719283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
    Alipour M; Khoobi M; Foroumadi A; Nadri H; Moradi A; Sakhteman A; Ghandi M; Shafiee A
    Bioorg Med Chem; 2012 Dec; 20(24):7214-22. PubMed ID: 23140986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
    Yan J; Sun L; Wu G; Yi P; Yang F; Zhou L; Zhang X; Li Z; Yang X; Luo H; Qiu M
    Bioorg Med Chem; 2009 Oct; 17(19):6937-41. PubMed ID: 19726199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
    Więckowska A; Bajda M; Guzior N; Malawska B
    Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
    Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.